| Christina Marie Solak, FNP-BC | |
|
600 Center St, Auburn, ME 04210-6311 | |
| (207) 955-5565 | |
| Not Available |
| Full Name | Christina Marie Solak |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 600 Center St, Auburn, Maine |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467108720 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | CNP211478 (Maine) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Convenientmd Llc | 2062667033 | 81 |
| Convenientmd - Ffs Uc Llc | 5193186492 | 311 |
News Archive
Ceregene, Inc., a biopharmaceutical company, announced today that enrollment is proceeding in a new Phase 1/2 clinical study evaluating CERE-120, a gene therapy product which delivers the neurotrophic factor neurturin, to dying neurons in Parkinson's disease patients. This new clinical study follows a completed Phase 2 trial and builds on experience gained in that trial, by enhancing the dosing regimen and optimizing the duration of patient follow up.
A clinical trial evaluates - in humans - a drug, device or mode of therapy for a disease. All therapies put into use in the U.S. go through a rigorous process of testing, culminating in evaluation of the treatment in human research participants. In order to test new treatments, clinical trial investigators at research institutions like UK must recruit participants willing to contribute to science, while often reaping the benefits of advanced treatment for themselves, and gaining access to top clinicians and the latest medical information.
Patients on antihypertensive medication who have high blood pressure in the morning, as measured with home monitoring kits, are at increased risk of cardiovascular events, even if their clinic measurement is acceptable, researchers have found.
A dose of 10 milligrams (mg) daily of S-equol delivered via a newly developed fermented soy germ-based nutritional supplement is as effective as a standard dose of soy isoflavones at reducing hot flash frequency significantly and is even more effective for relieving muscle and joint pain, according to a peer-reviewed study in US postmenopausal women published in the June Journal of Women's Health, available now as a Fast Track article online ahead of print.
Patients suffering from blockages of the arteries to the kidneys now have access to a new stenting treatment option with the launch today of Cook Medical's Formula Renal Balloon-Expandable Stent at the Society for Cardiovascular Angioplasty and Intervention 2011 Scientific Sessions.
› Verified 8 days ago
| Entity Name | Mainegeneral Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669423380 PECOS PAC ID: 1254245715 Enrollment ID: O20031118000718 |
News Archive
Ceregene, Inc., a biopharmaceutical company, announced today that enrollment is proceeding in a new Phase 1/2 clinical study evaluating CERE-120, a gene therapy product which delivers the neurotrophic factor neurturin, to dying neurons in Parkinson's disease patients. This new clinical study follows a completed Phase 2 trial and builds on experience gained in that trial, by enhancing the dosing regimen and optimizing the duration of patient follow up.
A clinical trial evaluates - in humans - a drug, device or mode of therapy for a disease. All therapies put into use in the U.S. go through a rigorous process of testing, culminating in evaluation of the treatment in human research participants. In order to test new treatments, clinical trial investigators at research institutions like UK must recruit participants willing to contribute to science, while often reaping the benefits of advanced treatment for themselves, and gaining access to top clinicians and the latest medical information.
Patients on antihypertensive medication who have high blood pressure in the morning, as measured with home monitoring kits, are at increased risk of cardiovascular events, even if their clinic measurement is acceptable, researchers have found.
A dose of 10 milligrams (mg) daily of S-equol delivered via a newly developed fermented soy germ-based nutritional supplement is as effective as a standard dose of soy isoflavones at reducing hot flash frequency significantly and is even more effective for relieving muscle and joint pain, according to a peer-reviewed study in US postmenopausal women published in the June Journal of Women's Health, available now as a Fast Track article online ahead of print.
Patients suffering from blockages of the arteries to the kidneys now have access to a new stenting treatment option with the launch today of Cook Medical's Formula Renal Balloon-Expandable Stent at the Society for Cardiovascular Angioplasty and Intervention 2011 Scientific Sessions.
› Verified 8 days ago
| Entity Name | Convenientmd Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710402359 PECOS PAC ID: 2062667033 Enrollment ID: O20180220000535 |
News Archive
Ceregene, Inc., a biopharmaceutical company, announced today that enrollment is proceeding in a new Phase 1/2 clinical study evaluating CERE-120, a gene therapy product which delivers the neurotrophic factor neurturin, to dying neurons in Parkinson's disease patients. This new clinical study follows a completed Phase 2 trial and builds on experience gained in that trial, by enhancing the dosing regimen and optimizing the duration of patient follow up.
A clinical trial evaluates - in humans - a drug, device or mode of therapy for a disease. All therapies put into use in the U.S. go through a rigorous process of testing, culminating in evaluation of the treatment in human research participants. In order to test new treatments, clinical trial investigators at research institutions like UK must recruit participants willing to contribute to science, while often reaping the benefits of advanced treatment for themselves, and gaining access to top clinicians and the latest medical information.
Patients on antihypertensive medication who have high blood pressure in the morning, as measured with home monitoring kits, are at increased risk of cardiovascular events, even if their clinic measurement is acceptable, researchers have found.
A dose of 10 milligrams (mg) daily of S-equol delivered via a newly developed fermented soy germ-based nutritional supplement is as effective as a standard dose of soy isoflavones at reducing hot flash frequency significantly and is even more effective for relieving muscle and joint pain, according to a peer-reviewed study in US postmenopausal women published in the June Journal of Women's Health, available now as a Fast Track article online ahead of print.
Patients suffering from blockages of the arteries to the kidneys now have access to a new stenting treatment option with the launch today of Cook Medical's Formula Renal Balloon-Expandable Stent at the Society for Cardiovascular Angioplasty and Intervention 2011 Scientific Sessions.
› Verified 8 days ago
| Entity Name | Convenientmd - Ffs Uc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780375220 PECOS PAC ID: 5193186492 Enrollment ID: O20230803000124 |
News Archive
Ceregene, Inc., a biopharmaceutical company, announced today that enrollment is proceeding in a new Phase 1/2 clinical study evaluating CERE-120, a gene therapy product which delivers the neurotrophic factor neurturin, to dying neurons in Parkinson's disease patients. This new clinical study follows a completed Phase 2 trial and builds on experience gained in that trial, by enhancing the dosing regimen and optimizing the duration of patient follow up.
A clinical trial evaluates - in humans - a drug, device or mode of therapy for a disease. All therapies put into use in the U.S. go through a rigorous process of testing, culminating in evaluation of the treatment in human research participants. In order to test new treatments, clinical trial investigators at research institutions like UK must recruit participants willing to contribute to science, while often reaping the benefits of advanced treatment for themselves, and gaining access to top clinicians and the latest medical information.
Patients on antihypertensive medication who have high blood pressure in the morning, as measured with home monitoring kits, are at increased risk of cardiovascular events, even if their clinic measurement is acceptable, researchers have found.
A dose of 10 milligrams (mg) daily of S-equol delivered via a newly developed fermented soy germ-based nutritional supplement is as effective as a standard dose of soy isoflavones at reducing hot flash frequency significantly and is even more effective for relieving muscle and joint pain, according to a peer-reviewed study in US postmenopausal women published in the June Journal of Women's Health, available now as a Fast Track article online ahead of print.
Patients suffering from blockages of the arteries to the kidneys now have access to a new stenting treatment option with the launch today of Cook Medical's Formula Renal Balloon-Expandable Stent at the Society for Cardiovascular Angioplasty and Intervention 2011 Scientific Sessions.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christina Marie Solak, FNP-BC 360 Us Highway 1 Byp Unit 102, Portsmouth, NH 03801-7105 Ph: (603) 410-6700 | Christina Marie Solak, FNP-BC 600 Center St, Auburn, ME 04210-6311 Ph: (207) 955-5565 |
News Archive
Ceregene, Inc., a biopharmaceutical company, announced today that enrollment is proceeding in a new Phase 1/2 clinical study evaluating CERE-120, a gene therapy product which delivers the neurotrophic factor neurturin, to dying neurons in Parkinson's disease patients. This new clinical study follows a completed Phase 2 trial and builds on experience gained in that trial, by enhancing the dosing regimen and optimizing the duration of patient follow up.
A clinical trial evaluates - in humans - a drug, device or mode of therapy for a disease. All therapies put into use in the U.S. go through a rigorous process of testing, culminating in evaluation of the treatment in human research participants. In order to test new treatments, clinical trial investigators at research institutions like UK must recruit participants willing to contribute to science, while often reaping the benefits of advanced treatment for themselves, and gaining access to top clinicians and the latest medical information.
Patients on antihypertensive medication who have high blood pressure in the morning, as measured with home monitoring kits, are at increased risk of cardiovascular events, even if their clinic measurement is acceptable, researchers have found.
A dose of 10 milligrams (mg) daily of S-equol delivered via a newly developed fermented soy germ-based nutritional supplement is as effective as a standard dose of soy isoflavones at reducing hot flash frequency significantly and is even more effective for relieving muscle and joint pain, according to a peer-reviewed study in US postmenopausal women published in the June Journal of Women's Health, available now as a Fast Track article online ahead of print.
Patients suffering from blockages of the arteries to the kidneys now have access to a new stenting treatment option with the launch today of Cook Medical's Formula Renal Balloon-Expandable Stent at the Society for Cardiovascular Angioplasty and Intervention 2011 Scientific Sessions.
› Verified 8 days ago
Laurie Lambert, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10 Minot Ave, Auburn, ME 04210 Phone: 207-729-7800 Fax: 207-795-2000 | |
Kara Clark, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 15 Gracelawn Rd, Auburn, ME 04210 Phone: 207-753-3080 Fax: 207-753-3088 | |
Corinna M Campbell, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 791 Turner St Unit 2, Auburn, ME 04210 Phone: 207-330-3900 Fax: 207-330-3940 | |
Jennifer Sullivan, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 15 Gracelawn Rd Ste 203, Auburn, ME 04210 Phone: 207-777-8959 Fax: 207-753-3093 | |
Kelly A Johnson, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2 Great Falls Plz Ste 21, Auburn, ME 04210 Phone: 207-330-3950 Fax: 207-330-3955 | |
Erin P Stone, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 236 Stetson Rd, Auburn, ME 04210 Phone: 207-333-6300 | |
Elise Ann K Wiley, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 60 Second Street, Auburn, ME 04210 Phone: 207-783-3333 Fax: 207-782-9723 |